Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033514
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2002-04-09
Brief Title:
Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2Neu Overexpression
Sponsor:
Organization:
Jonsson Comprehensive Cancer Center